Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tumor
Clinical trial NCT04013048 · COMPLETED
Trial details
- NCT number
- NCT04013048
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-08
- Primary completion
- 2019-12-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.